Vogt AW - Search Results

1

Long Q-T syndrome associated with oral erythromycin used in preoperative bowel preparation.

Vogt AW, Zollo RA. Vogt AW, et al. Anesth Analg. 1997 Nov;85(5):1011-3. doi: 10.1097/00000539-199711000-00010. Anesth Analg. 1997. PMID: 9356092 No abstract available.

2

Unindicated preoperative testing: ASA physical status and financial implications.

Vogt AW, Henson LC. Vogt AW, et al. J Clin Anesth. 1997 Sep;9(6):437-41. doi: 10.1016/s0952-8180(97)00060-3. J Clin Anesth. 1997. PMID: 9278827 Free article.

3

Penile block timing for postoperative analgesia of hypospadias repair in children.

Chhibber AK, Perkins FM, Rabinowitz R, Vogt AW, Hulbert WC. Chhibber AK, et al. Among authors: vogt aw. J Urol. 1997 Sep;158(3 Pt 2):1156-9. doi: 10.1097/00005392-199709000-00118. J Urol. 1997. PMID: 9258161 Free article. Clinical Trial.

4

Postoperative lactic acidosis in patients receiving metformin.

Lustik SJ, Vogt A, Chhibber AK. Lustik SJ, et al. Anesthesiology. 1998 Jul;89(1):266-7; author reply 267-8. doi: 10.1097/00000542-199807000-00037. Anesthesiology. 1998. PMID: 9667320 Free article. No abstract available.

5

Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial.

Moriarty PM, Parhofer KG, Babirak SP, Cornier MA, Duell PB, Hohenstein B, Leebmann J, Ramlow W, Schettler V, Simha V, Steinhagen-Thiessen E, Thompson PD, Vogt A, von Stritzky B, Du Y, Manvelian G. Moriarty PM, et al. Eur Heart J. 2016 Dec 21;37(48):3588-3595. doi: 10.1093/eurheartj/ehw388. Epub 2016 Aug 29. Eur Heart J. 2016. PMID: 27572070 Free PMC article. Clinical Trial.

6

Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial.

Moriarty PM, Parhofer KG, Babirak SP, deGoma E, Duell PB, Hohenstein B, Ramlow W, Simha V, Steinhagen-Thiessen E, Thompson PD, Vogt A, von Stritzky B, Du Y, Manvelian G. Moriarty PM, et al. J Clin Lipidol. 2016 May-Jun;10(3):627-34. doi: 10.1016/j.jacl.2016.02.003. Epub 2016 Feb 18. J Clin Lipidol. 2016. PMID: 27206951 Clinical Trial.

7

The potential of mipomersen, an ApoB synthesis inhibitor, to reduce necessity for LDL-apheresis in patients with heterozygous familial hypercholesterolemia and coronary artery disease.

Vogt A, Parhofer KG. Vogt A, et al. Expert Opin Pharmacother. 2013 Apr;14(6):691-7. doi: 10.1517/14656566.2013.779253. Epub 2013 Mar 11. Expert Opin Pharmacother. 2013. PMID: 23477485 Clinical Trial.

8

Does regular lipid apheresis in patients with isolated elevated lipoprotein(a) levels reduce the incidence of cardiovascular events?

Rosada A, Kassner U, Vogt A, Willhauck M, Parhofer K, Steinhagen-Thiessen E. Rosada A, et al. Artif Organs. 2014 Feb;38(2):135-41. doi: 10.1111/aor.12135. Epub 2013 Jul 25. Artif Organs. 2014. PMID: 23889507

9

Quality of life in patients treated with lipoprotein apheresis.

Rosada A, Kassner U, Banisch D, Bender A, Steinhagen-Thiessen E, Vogt A. Rosada A, et al. J Clin Lipidol. 2016 Mar-Apr;10(2):323-9.e6. doi: 10.1016/j.jacl.2015.12.009. Epub 2015 Dec 22. J Clin Lipidol. 2016. PMID: 27055963

10

Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study).

Waldmann E, Vogt A, Crispin A, Altenhofer J, Riks I, Parhofer KG. Waldmann E, et al. Atherosclerosis. 2017 Apr;259:20-25. doi: 10.1016/j.atherosclerosis.2017.02.019. Epub 2017 Feb 24. Atherosclerosis. 2017. PMID: 28279833 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page